As a global contract research organization, headquartered in Waltham, Massachusetts, AsisChem serves the pharmaceutical and biotechnology industries in the area of new drug research and discovery.
Hundreds of organizations have used AsisChem's services since its inception in 2003. More than half of AsisChem's current customers are pharmaceutical and biotechnology companies and we are a preferred partner for dozens of universities and non-profit institutions world wide.
We make the drug discovery process more efficient and cost effective while maintaining the highest standards of quality and reliability to our clients.
AsisChem's synthetic team of chemists has three core groups: medicinal chemistry support, process optimization and research. Our internationally trained chemists work on custom projects designed specifically for the needs of each client. AsisChem also maintains an extensive catalog of building blocks and readily available screening compounds.
Our goal is to help our customers succeed in design, development, synthesis and scale-up of the best lead molecules worldwide. This goal is seen and maintained from the executive team to our team of scientists to the administrative and support teams.
Quality. Availability. Diversity. Expertise.
Quality. AsisChem maintains at least, if not greater than, 95% purity with an enantiomeric ratio average of 99%, so you do not have to trade quality for convenience.
Availability. We maintain significant stock of our most popular compounds, so we can deliver what you need, when you need it.
Diversity. AsisChem offers multiple unnatural amino acids, fire retardants, epigenetics, and many industry leading discovery products.
Expertise. Let AsisChem put its best Ph.D. experts in medicinal or synthetic chemistry at your service to assist you with your custom research or production projects. If we don't already have the compound you are looking for, we can certainly design a custom synthesis and make it for you!
As the Chief Executive Officer and Founder, Dr. Kuchuk leads AsisChem's senior management team in setting the company's strategic direction, while engaging directly with customers and partners from around the world. He has over twenty years of experience in industry and university research with an extensive background in general management and business development. His prior experience includes his work for Starks Associates where he excelled in process development and preparation of drug candidates and became an expert in a variety of custom projects. He also worked for Scoros International, Inc. managing dedicated R&D operations for its clients and served as a President of ILLA International, world leader in licensing of phenol technologies. Dr. Kuchuk received his M.S. and Ph.D. degrees from St. Petersburg State University, Russia followed by postdoctoral trainings and fellowships at Göttingen University, the Ohio State University and University of Indiana, Bloomington.
Dr. Esikov has over twenty years of experience in synthetic organic chemistry. He is an expert in the field of chemistry of heterocyclic compounds. After obtaining a Ph.D. in Organic Chemistry from St. Petersburg State Institute of Technology, Russia, Dr. Esikov worked at Lund University, Lund, Sweden, and at Irix Pharmaceuticals, Inc., Florence, South Carolina.
Dr. Joel Berniac has over 15 years of experience in Medicinal Chemistry and drug discovery. After obtaining a Ph.D. in Organic Chemistry from the University of Notre Dame in Indiana, Dr. Berniac worked at Bayer Pharmaceuticals where he managed a fully equipped medicinal chemistry laboratory and worked in rational drug design, hit-to-lead, lead optimization, and pre-clinical candidate selection including animal models, pharmaco-kinetics, pharmaco-dynamics, oral bioavailability and blood-brain barrier permeability.
Jim Elgart is a financial professional and entrepreneur with two decades of experience in building businesses and the necessary infrastructure for those businesses to succeed. Jim has effectively built businesses in Latin America, North America, and Europe. Jim is currently the part-time CFO of Jove (the Journal of Visualized Experiments), AsisChem, Inc., and Human Capital Consultants. Jim earned his BA in economics from Boston University as well as an MBA and MA in Latin American Studies from Tulane University. Jim is a Licensed CPA in Massachusetts.
Sonya Iverson is a molecular biologist and biotech communications specialist with fifteen years of academic research experience ranging from transgenic mouse models to synthetic biology in E. coli. Familiarity with cellular biology methods, microscopy, immunohistochemistry, tissue preparation, genetic engineering, flow cytometry and other specialized research methods enables Sonya to communicate with research scientists interested in unique compounds and custom synthesis. Sonya focuses on developing AsisChem's ever expanding product catalog and communicating with researchers as a technical support scientist. She earned her Ph.D in Molecular and Cellular Biology and Biochemistry from Boston University.